Cited by 132Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and ApplicationsAlzheimer's disease research and treatments

New MRI markers for Alzheimer’s disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements

Clerx, Lies, Visser, Pieter Jelle, Verhey, Frans, Aalten, Pauline·2012·Journal of Alzheimer s Disease

Abstract

The aim of the present study is to evaluate the diagnostic value of diffusion tensor imaging (DTI) for early Alzheimer's disease (AD) in comparison to widely accepted medial temporal lobe (MTL) atrophy measurements. A systematic literature research was performed into DTI and MTL atrophy in AD and mild cognitive impairment (MCI). We included seventy-six studies on MTL atrophy including 8,122 subjects and fifty-five DTI studies including 2,791 subjects. Outcome measure was the effect size (ES) expressed as Hedges g. In volumetric studies, atrophy of the MTL significantly differentiated between AD and controls (ES 1.32-1.98) and MCI and controls (ES 0.61-1.46). In DTI-Fractional anisotropy (FA) studies, the total cingulum differentiated best between AD and controls (ES = 1.73) and the parahippocampal cingulum between MCI and controls (ES = 0.97). In DTI-Mean diffusivity (MD) studies, the hippocampus differentiated best between AD and controls (ES = -1.17) and between MCI and controls (ES = -1.00). We can conclude that in general, the ES of volumetric MTL atrophy measurements was equal or larger than that of DTI measurements. However, for the comparison between controls and MCI-patients, ES of hippocampal MD was larger than ES of hippocampal volume. Furthermore, it seems that MD values have somewhat more discriminative power than FA values with higher ES in the frontal, parietal, occipital and temporal lobe.

Integrity signals

Registry

Crossref · 10.3233/jad-2011-110797

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For all analyses, mean diffusivity was used as the primary DTI measure in autosomal-dominant Alzheimer's disease because previous studies found mean diffusivity to be the most sensitive DTI marker to detect fibre tract alterations.

    “For all analyses, we used mean diffusivity as our primary DTI measure in autosomal-dominant Alzheimer’s disease, since previous studies found mean diffusivity to be the most sensitive DTI marker to detect fibre tract alterations (Clerx et al., 2012; Nowrangi et al., 2013).”
  • Lower FADTI and higher MDDTI are most frequently reported in studies of AD.

    “Lower FADTI and higher MDDTI are most frequently reported in studies of AD (Kavcic et al., 2008; Clerx et al., 2012; Nir et al., 2013; Maggipinto et al., 2017; Mayo et al., 2017)”

The citation lists haven’t been fetched yet

References 174 · Cited by 132

Authors
Clerx, L., Visser, P. J., Verhey, F., & Aalten, P.
Affiliations
Maastricht University Medical Centre (NL)
Corresponding author
Clerx, Lies
Venue
Journal of Alzheimer s Disease
Published
2012-03-20
Volume
29
Issue
2
Pages
405-429
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2105474070
Cited by
132
References
174
Citations by year
2025: 4 · 2024: 1 · 2023: 3 · 2022: 6 · 2021: 8 · 2020: 4 · 2019: 12 · 2018: 8 · 2017: 14 · 2016: 14 · 2015: 19 · 2014: 14 · 2013: 22 · 2012: 3
FWCI
2.53
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, mild cognitive impairment
MeSH terms
Adult, Aged, Alzheimer Disease, Atrophy, Female, Humans, Image Processing, Computer-Assisted, Male, Middle Aged, Neuropsychological Tests, Temporal Lobe, PubMed, Diffusion Tensor Imaging, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review